![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Protherics (MM) | NASDAQ:PTIL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.30 | 0 | 01:00:00 |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
22 July 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange Act of 1934.
Yes No X
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .
The Registrant is furnishing a copy of its announcements as reported to the Company Announcements Office of the London Stock Exchange.
Protherics PLC
2008 Annual General Meeting Results
Lon
don, UK; Brentwood, TN, US: 22 July 2008
-
Protherics PLC (the
“Company”), the international biopharmaceutical company focused on critical
care and cancer, is pleased to announce that Resolutions 1 to 7 and 9 to 11 put forward at
the Annual General Meeting of the Company held earlier today were passed. Since Resolution
7 was passed, Resolution 8 was withdrawn.
The proxy figures for the Resolutions are set out below and will shortly be displayed on
the Company’s website at
www.protherics.com
.
Resolution Number (as noted on proxy form) |
Shares For |
Shares Discretionary |
Shares Against |
Shares Marked As Votes Withheld/ Abstentions |
Poll
|
|
1 |
To receive the Financial Statements for the year ended 31 March 2007 together with the reports of the Directors and Auditors. |
227,968,493 |
616,122 |
349,378 |
1,776 |
No |
2 |
To elect R B Soderstrom as a Director. |
228,087,050 |
613,554 |
172,810 |
62,355 |
No |
3 |
To reappoint KPMG Audit Plc as Auditors of the Company. |
228,114,010 |
624,117 |
190,689 |
6,953 |
No |
4 |
To authorise the Directors to set the remuneration of the Auditors. |
228,147,226 |
618,045 |
163,724 |
6,774 |
No |
5 |
To approve the Directors’ Remuneration Report for the year ended 31 March 2008. |
152,200,073 |
610,805 |
59,894,074 |
16,230,817 |
No |
6 |
To authorise the Directors to allot shares pursuant to Section 80 of the Companies Act 1985 (the “Act”) |
227,624,529 |
615,890 |
607,360 |
87,990 |
No |
7 |
To authorise the Directors to disapply pre-emption rights pursuant to Section 95 of the Act (10%). |
220,212,918 |
627,390 |
3,747,064 |
4,348,397 |
No |
8 |
To authorise the Directors to disapply pre-emption rights pursuant to Section 95 of the Act (5%). |
228,076,114 |
622,456 |
143,951 |
93,248 |
No |
9 |
To receive and adopt the amended Articles of Association. |
228,004,502 |
639,725 |
189,939 |
101,603 |
No |
10 |
To approve and adopt the Protherics PLC 2008 Savings-Related Share Option Scheme. |
228,181,154 |
625,467 |
97,992 |
31,156 |
No |
11 |
To authorise the Directors to make amendments to the Protherics PLC 1996 unapproved Share Option Scheme |
228,123,047 |
636,098 |
142,146 |
34,478 |
No |
The full text of the resolutions together with the related Circular to Shareholders can be viewed at:
The Document Viewing Facility
The Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS
| Ends |
F or f urther i nformation please contact :
Protherics |
|
Nick Staples, Director of Corporate Affairs |
+44 (0) 7919 480510 |
Julie Vickers, Company Secretary |
+44 (0)1928 518000 |
Financial Dynamics – press enquiries |
|
London: Ben Atwell, Lara Mott |
+44 (0) 20 7831 3113 |
New York: John Capodanno |
+1 212 850 5600 |
Or visi t www.protherics.com
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PROTHERICS PLC |
||||||||
Date: 22 July 2008 |
By: |
/s/ Rolf Soderstrom |
||||||
Rolf Soderstrom |
||||||||
Finance Director |
1 Year Protherics Chart |
1 Month Protherics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions